Medical Condition News

RSS

EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC

Eli Lilly and Company announced today that the European Commission has granted approval for the use of ALIMTA (pemetrexed for injection) as a single agent for continuation maintenance therapy in patients with a particular type of lung cancer, called advanced nonsquamous non-small cell lung cancer

29 Oct 2011

Cardiovascular Associates reaches definitive agreement with ABHS

Cardiovascular Associates (CVA), one of the leading cardiovascular care practices, and Alexian Brothers Health System (ABHS) have reached a definitive agreement to formally align the two prestigious organizations. The agreement will form the Alexian Brothers Heart and Vascular Institute and provide the framework that will continue to grow ABHS's reputation as a center of cardiac care excellence and innovation.

29 Oct 2011

Wintertime skin care tips

Winter time woes extend beyond cold temperatures and sometimes gloomy weather. Your skin can react to the constant temperature changes as you move indoor to outdoor for daily living activities. Rita Pichardo-Geisinger, M.D., of the Wake Forest Baptist Medical Center dermatology department, is part of an internationally renowned team of clinicians who provide clinical care for patients. Pichardo-Geisinger provides these tips that are easy to incorporate into your daily routine to help keep your skin and hair in prime condition.

29 Oct 2011

New drug could combat cardiovascular disease

A new therapy being studied in non-human primates by researchers at Wake Forest Baptist Medical Center and colleagues is demonstrating promise as a potential tool for combating cardiovascular disease by increasing good cholesterol and lowering triglycerides in the blood.

29 Oct 2011

Spinal USA to introduce two new solutions at NASS meeting

Spinal USA, LLC announced today that it will introduce two new additions to the company's portfolio of spinal treatment solutions at this year's meeting of the North American Spine Society (NASS) in Chicago, IL, November 1-5.

29 Oct 2011

Varian to supply TrueBeam treatment systems to Lund University Hospital

Varian Medical Systems has been awarded a contract to supply four TrueBeam treatment systems to Lund University Hospital in Sweden, one of the country's largest radiotherapy departments. The order, confirmed in September, is aimed at cutting treatment waiting lists in the Skane region of Sweden and includes an option to acquire two further TrueBeam systems in 2014.

28 Oct 2011

NHS must plan to deal with predicted 45% leap in new cancer cases

The NHS must start planning now to deal with a predicted leap of 45 per cent in the number of new cancer cases in the UK over the next two decades, Cancer Research UK warns today (Friday).

28 Oct 2011

Potential avenue to make an unhealthy heart grow more like a healthy version

Identification of three fatty acids involved in the extreme growth of Burmese pythons' hearts following large meals could prove beneficial in treating diseased human hearts, according to research co-authored by a University of Alabama scientist and publishing in the Oct. 28 issue of Science.

28 Oct 2011

Scientists challenge theory about why chemotherapy agents target cancer

Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.

28 Oct 2011

Two new studies could provide tools to prevent rehospitalizations after major surgeries

Studies have shown that patients returning to the hospital soon after they've been discharged may cost Medicare up to billions of dollars each year, but two new studies presented at the 2011 Annual Clinical Congress of the American College of Surgeons could give surgical teams and their patients tools to prevent rehospitalizations.

28 Oct 2011

Platform approach to chemically incorporate homing receptors onto surface of cells

Stem cell therapies hold enormous potential to address some of the most tragic illnesses, diseases, and tissue defects world-wide. However, the inability to target cells to tissues of interest poses a significant barrier to effective cell therapy.

28 Oct 2011

Scientists describe how protein acts as courier in cell signaling pathways

Normal development, from fertilized egg to adult organism, depends on each cell receiving proper instructions from its environment. In response to such incoming information, receptors on a cell's surface send signals to the nucleus that tweak gene expression and control cellular function.

28 Oct 2011

Patients with ANCA-associated vasculitis harbor Flt1 protein that blocks blood vessel repair

In some kidney diseases, patients have high blood levels of a protein that blocks blood vessel repair, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

28 Oct 2011

Three economic indicators linked with high risk of stroke

People living in poor countries or countries that spend proportionately less on health-care are about 30 per cent more likely to have a stroke, a new study shows.

28 Oct 2011

Functional link between IKBKE and Akt activation in breast cancer

Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer.

28 Oct 2011

Special hospital team reduces cumulated risk of stroke in TIA patients

Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team.

28 Oct 2011

Social stressors around the transition into adulthood sow seeds of disease in middle age

Being hard up socially and financially during adolescence and early adulthood takes its toll on the body, and leads to physiological wear and tear in middle aged men and women, irrespective of how tough things have been in the interim. According to Dr. Per E. Gustafsson from Umeå University in Sweden and colleagues, experience of social and material stressors around the time of transition into adulthood is linked to a rise in disease risk factors in middle age, including higher blood pressure, body weight and cholesterol.

28 Oct 2011

Researchers explore novel therapeutic approach for thyroid cancer

Some forms of differentiated thyroid cancer (DTC) respond to treatment with radioactive iodine, which is taken up by the thyroid gland, destroying the cancerous cells. However patients with two forms of thyroid cancer, radioiodine-refractory DTC and anaplastic thyroid cancer (ATC), do not benefit from radioiodine therapy, and other treatment options are limited.

28 Oct 2011

Researchers announce new method to build important heparin drug

Robert Linhardt is working to forever change the way some of the most widely used drugs in the world are manufactured. Today, in the journal Science, he and his partner in the research, Jian Liu, have announced an important step toward making this a reality. The discovery appears in the October 28, 2011 edition of the journal Science in a paper titled "chemoenzymatic synthesis of homogeneous ultra-low molecular weight heparins."

28 Oct 2011

ACR supports Diagnostic Imaging Services Protection Act

The American College of Radiology supports the Diagnostic Imaging Services Protection Act (H.R. 3269), which would prohibit any multiple procedure payment reduction to the "professional component" of CT, MRI and ultrasound exams received by the same patient, on the same day, in the same setting in 2012.

28 Oct 2011